KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to $39.5 million.

  • Petmed Express' Non-Current Assets fell 4836.02% to $39.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $39.5 million, marking a year-over-year decrease of 4836.02%. This contributed to the annual value of $69.8 million for FY2025, which is 840.42% down from last year.
  • As of Q4 2025, Petmed Express' Non-Current Assets stood at $39.5 million, which was down 4836.02% from $40.8 million recorded in Q3 2025.
  • Over the past 5 years, Petmed Express' Non-Current Assets peaked at $79.5 million during Q2 2023, and registered a low of $25.5 million during Q4 2021.
  • Over the past 5 years, Petmed Express' median Non-Current Assets value was $40.2 million (recorded in 2025), while the average stood at $49.9 million.
  • Per our database at Business Quant, Petmed Express' Non-Current Assets skyrocketed by 16008.9% in 2023 and then crashed by 4836.02% in 2025.
  • Quarter analysis of 5 years shows Petmed Express' Non-Current Assets stood at $25.5 million in 2021, then skyrocketed by 39.45% to $35.6 million in 2022, then soared by 118.57% to $77.8 million in 2023, then decreased by 1.79% to $76.4 million in 2024, then tumbled by 48.36% to $39.5 million in 2025.
  • Its Non-Current Assets was $39.5 million in Q4 2025, compared to $40.8 million in Q3 2025 and $41.9 million in Q2 2025.